EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma

Karan L Chohan, Stephen M Ansell

Clinical Lymphoma Myeloma and Leukemia · 2023

DOI: 10.1016/j.clml.2023.06.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023. Verfasst von Karan L Chohan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic, Rochester MN. Hauptthemen laut MEDLINE: Hodgkin Disease, Immunoconjugates. Die Arbeit nennt 114 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseImmunoconjugatesHumansBrentuximab VedotinMolecular Targeted TherapyBiology

Stichwörter der Autor:innen

Hodgkin lymphomaLymphoid malignanciesNovel therapiesTargeted therapiesTumor immune microenvironment

Substanzen

Brentuximab VedotinImmunoconjugates

Autor:innen und Institutionen

  • Department of Medicine, Mayo Clinic, Rochester MN.
  • Division of Hematology, Mayo Clinic, Rochester MN. Electronic address: ansell.stephen@mayo.edu.

Zitieren

APA

Chohan, K. L., & Ansell, S. M. (2023). SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2023.06.006

Vancouver

Chohan KL, Ansell SM. SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia. 2023. doi:10.1016/j.clml.2023.06.006

BibTeX
@article{Chohan2023,
  author = {Chohan, Karan L and Ansell, Stephen M},
  title = {SOHO State of the Art Updates and Next Questions | From Biology to Therapy: Progress in Hodgkin Lymphoma},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2023},
  doi = {10.1016/j.clml.2023.06.006}
}
Kostenlos starten →